Caraco rolls out generic version of Optivar
Caraco Pharmaceutical Laboratories Ltd. has begun shipping azelastine ophthalmic solution 0.05%. The company said Tuesday that the product was recently approved by the Food and Drug Administration for Sun Pharma’s abbreviated new drug application.